Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02986815 : [11C]Acetate PET in Patients With Glioma
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Male or female, age 18 and older, of any ethnic group

- Spanish-speaking patients will be eligible

- Histological diagnosis of glioma or

- Brain MR imaging suggestive of a glioma or 2HG > 2mM by MR spectroscopy in patients
who have not had a surgical procedure to establish the diagnosis.

- Karnofsky Performance status > 70%

- Negative serum pregnancy test or child bearing potential terminated by surgery,
radiation, menopause or current use of two approved methods of birth control

- Patient able and willing to provide informed consent

Exclusion Criteria:

- Patient or legal parent/guardian unable to provide informed consent

- Psychiatric or addictive disorders that preclude obtaining informed consent

- Karnofsky Performance status < 70%

- NYHA class III and IV congestive heart failure

- Unstable angina

- Pregnant or lactating women

- Women of childbearing potential who refuse a pregnancy test
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02986815      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740